Myriad Genetics Inc (MYGN)
17.60
-0.24
(-1.32%)
USD |
NASDAQ |
Nov 05, 16:00
17.50
-0.10
(-0.54%)
After-Hours: 16:19
Myriad Genetics Price to Book Value: 2.158 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.187 |
| November 01, 2024 | 2.206 |
| October 31, 2024 | 2.693 |
| October 30, 2024 | 2.793 |
| October 29, 2024 | 2.731 |
| October 28, 2024 | 2.693 |
| October 25, 2024 | 2.644 |
| October 24, 2024 | 2.675 |
| October 23, 2024 | 2.738 |
| October 22, 2024 | 2.774 |
| October 21, 2024 | 2.764 |
| October 18, 2024 | 2.869 |
| October 17, 2024 | 2.861 |
| October 16, 2024 | 2.934 |
| October 15, 2024 | 2.941 |
| October 14, 2024 | 3.078 |
| October 11, 2024 | 2.953 |
| October 10, 2024 | 2.830 |
| October 09, 2024 | 2.989 |
| October 08, 2024 | 3.184 |
| October 07, 2024 | 3.206 |
| October 04, 2024 | 3.246 |
| October 03, 2024 | 3.242 |
| October 02, 2024 | 3.307 |
| October 01, 2024 | 3.315 |
| Date | Value |
|---|---|
| September 30, 2024 | 3.359 |
| September 27, 2024 | 3.245 |
| September 26, 2024 | 3.217 |
| September 25, 2024 | 3.200 |
| September 24, 2024 | 3.256 |
| September 23, 2024 | 3.303 |
| September 20, 2024 | 3.39 |
| September 19, 2024 | 3.470 |
| September 18, 2024 | 3.492 |
| September 17, 2024 | 3.508 |
| September 16, 2024 | 3.422 |
| September 13, 2024 | 3.384 |
| September 12, 2024 | 3.237 |
| September 11, 2024 | 3.223 |
| September 10, 2024 | 3.316 |
| September 09, 2024 | 3.329 |
| September 06, 2024 | 3.308 |
| September 05, 2024 | 3.392 |
| September 04, 2024 | 3.110 |
| September 03, 2024 | 3.368 |
| August 30, 2024 | 3.475 |
| August 29, 2024 | 3.473 |
| August 28, 2024 | 3.427 |
| August 27, 2024 | 3.373 |
| August 26, 2024 | 3.391 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6768
Minimum
Mar 18 2020
3.508
Maximum
Sep 17 2024
2.073
Average
2.094
Median
Jul 26 2022
Price to Book Value Benchmarks
| Boston Scientific Corp | 6.089 |
| Abbott Laboratories | 5.130 |
| Personalis Inc | 2.664 |
| Perspective Therapeutics Inc | 2.440 |
| Electromed Inc | 4.536 |
Price to Book Value Related Metrics
| PS Ratio | 1.913 |
| Price | 17.60 |
| Earnings Yield | -10.29% |
| Market Cap | 1.598B |